Company intelligence / Profile preview

Resilience Therapeutics

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Resilience (National Resilience, Inc.) is a prominent CDMO specializing in advanced biomanufacturing. It offers comprehensive development and manufacturing services for a range of modalities including biologics, cell and gene therapies, vaccines, and nucleic acids. The company supports a diverse portfolio of clients from large pharmaceutical companies to small and mid-size biotechs, focusing on enhancing the biopharmaceutical supply chain.

Modalities: BiologicsCell therapyGene therapyVaccinesNucleic acidsViral vectorsProteins
Industry: Contract Manufacturing Organization

Partnerships

Portfolio of 65+ clients ranging from large pharma to small and mid-size biotech companies

Beyond the preview

Go deeper on Resilience Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resilience Therapeutics.

Explore the full profile